Harish Eswaran

Hematology | Oncology

7000 Fannin St
Ste 750
Houston, TX 77030

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Aortic mural thrombus: Individualized treatment for a heterogeneous disease?

Aortic mural thrombus: Individualized treatment for a heterogeneous disease?

Journal: Vascular medicine (London, England)

Published: August 31, 2026

Vascular Disease Patient Information Page: Hereditary hemorrhagic telangiectasia (HHT).

Vascular Disease Patient Information Page: Hereditary hemorrhagic telangiectasia (HHT).

Journal: Vascular medicine (London, England)

Published: February 03, 2026

Therapeutic Potential of C1-Inhibitor in Vascular Diseases and Beyond.

Therapeutic Potential of C1-Inhibitor in Vascular Diseases and Beyond.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: December 18, 2025

Cabozantinib and thromboembolism in patients with cancer: a systematic review, meta-analysis, and retrospective study.

Cabozantinib and thromboembolism in patients with cancer: a systematic review, meta-analysis, and retrospective study.

Journal: Blood advances

Published: August 12, 2025

Population-scale analysis reveals inherited C1-inhibitor deficiency is a polyphenotypic thrombotic disorder.

Population-scale analysis reveals inherited C1-inhibitor deficiency is a polyphenotypic thrombotic disorder.

Journal: Blood advances

Published: May 21, 2025

Population-scale Analysis Reveals Germline Loss of SERPING1 (C1-Inhibitor) is a Polyphenotypic Thrombotic Disorder.

Population-scale Analysis Reveals Germline Loss of SERPING1 (C1-Inhibitor) is a Polyphenotypic Thrombotic Disorder.

Journal: Blood advances

Published: May 21, 2025

Clinical strategies for management of abnormal uterine bleeding: hormonal and nonhormonal interventions in women at risk for venous thromboembolism.

Clinical strategies for management of abnormal uterine bleeding: hormonal and nonhormonal interventions in women at risk for venous thromboembolism.

Journal: Current opinion in obstetrics & gynecology

Published: April 15, 2025

Coagulation factor XII haploinsufficiency is protective against venous thromboembolism in a population-scale multidimensional analysis.

Coagulation factor XII haploinsufficiency is protective against venous thromboembolism in a population-scale multidimensional analysis.

Journal: Nature communications

Published: February 19, 2025

Potential and emerging therapeutics for HHT.

Potential and emerging therapeutics for HHT.

Journal: Hematology. American Society of Hematology. Education Program

Published: December 07, 2024

Livedoid vasculopathy in hemoglobinopathy-associated chronic leg ulcers.

Livedoid vasculopathy in hemoglobinopathy-associated chronic leg ulcers.

Journal: Annals of hematology

Published: August 24, 2024

Characteristics of Peripheral Neuropathy in Patients With Livedoid Vasculopathy.

Characteristics of Peripheral Neuropathy in Patients With Livedoid Vasculopathy.

Journal: Journal of clinical neuromuscular disease

Published: February 22, 2023

Livedoid vasculopathy: A review with focus on terminology and pathogenesis.

Livedoid vasculopathy: A review with focus on terminology and pathogenesis.

Journal: Vascular medicine (London, England)

Published: October 26, 2022

Showing 1-12 of 19

Last Updated: 09/26/2026